Total Payments
$6,152
2022 Payments
$22.96
Companies
28
Transactions
343
Medicare Patients
9,728
Medicare Billing
$572,677
Payment Breakdown by Category
Food & Beverage$6,073 (98.7%)
Education$79.09 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,073 | 341 | 98.7% |
| Education | $79.09 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,327 | 85 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,266 | 56 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $455.37 | 18 | $0 (2021) |
| Genentech USA, Inc. | $406.04 | 25 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $358.31 | 22 | $0 (2022) |
| Lilly USA, LLC | $309.22 | 21 | $0 (2021) |
| Janssen Biotech, Inc. | $287.42 | 17 | $0 (2021) |
| Amgen Inc. | $235.58 | 7 | $0 (2020) |
| GENZYME CORPORATION | $230.20 | 14 | $0 (2021) |
| PFIZER INC. | $217.29 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $22.96 | 1 | Sun Pharmaceutical Industries Inc. ($22.96) |
| 2021 | $1,399 | 82 | AbbVie Inc. ($381.60) |
| 2020 | $1,071 | 59 | AbbVie Inc. ($280.32) |
| 2019 | $1,413 | 76 | Novartis Pharmaceuticals Corporation ($338.31) |
| 2018 | $1,089 | 64 | Novartis Pharmaceuticals Corporation ($258.87) |
| 2017 | $1,157 | 61 | Novartis Pharmaceuticals Corporation ($219.15) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Dermatology | ||||||
| 12/20/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Dermatology | ||||||
| 12/17/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Immunology | ||||||
| 12/06/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Immunology | ||||||
| 11/22/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Dermatology | ||||||
| 11/18/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2021 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: Dermatology | ||||||
| 11/02/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 10/27/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/02/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/25/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Immunology | ||||||
| 08/16/2021 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: BioOncology | ||||||
| 08/11/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/03/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $15.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 37 | 4,588 | 7,811 | $615,370 | $271,400 |
| 2020 | 34 | 5,140 | 8,686 | $668,370 | $301,277 |
Total Patients
9,728
Total Services
16,497
Medicare Billing
$572,677
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 981 | 1,213 | $84,910 | $38,383 | 45.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 778 | 1,033 | $103,300 | $33,893 | 32.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 428 | 478 | $62,140 | $29,380 | 47.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2021 | 66 | 78 | $31,590 | $23,885 | 75.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 467 | 763 | $30,520 | $21,880 | 71.7% |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 103 | 119 | $23,800 | $12,804 | 53.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 607 | 2,852 | $85,560 | $12,460 | 14.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 181 | 189 | $20,790 | $11,400 | 54.8% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 62 | 73 | $14,235 | $7,795 | 54.8% |
| 11642 | Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | Office | 2021 | 49 | 53 | $15,635 | $7,337 | 46.9% |
| 96567 | Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session | Office | 2021 | 66 | 73 | $10,850 | $6,728 | 62.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 47 | 56 | $14,560 | $6,024 | 41.4% |
| 17272 | Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | Office | 2021 | 42 | 47 | $9,635 | $5,460 | 56.7% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 22 | 22 | $7,260 | $5,207 | 71.7% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 25 | 26 | $8,970 | $5,146 | 57.4% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2021 | 60 | 65 | $10,400 | $5,095 | 49.0% |
| 12053 | Repair of wound (5.1 to 7.5 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 15 | 16 | $5,560 | $4,187 | 75.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 98 | 98 | $9,310 | $3,797 | 40.8% |
| 17271 | Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals | Office | 2021 | 44 | 49 | $9,065 | $3,619 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 101 | $8,825 | $3,545 | 40.2% |
| 17282 | Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 27 | 29 | $6,670 | $3,397 | 50.9% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 39 | 43 | $5,805 | $3,227 | 55.6% |
| 17263 | Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs | Office | 2021 | 17 | 18 | $3,780 | $2,392 | 63.3% |
| 11311 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 27 | 30 | $4,200 | $2,204 | 52.5% |
| 11643 | Removal of malignant growth (2.1 to 3.0 centimeters) of the face, ears, eyelids, nose, or lips | Office | 2021 | 15 | 16 | $5,760 | $2,142 | 37.2% |
About Dr. Donald Sharp, M.D
Dr. Donald Sharp, M.D is a Specialist healthcare provider based in Oak Ridge, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780652230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Sharp, M.D has received a total of $6,152 in payments from pharmaceutical and medical device companies, with $22.96 received in 2022. These payments were reported across 343 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,073).
As a Medicare-enrolled provider, Sharp has provided services to 9,728 Medicare beneficiaries, totaling 16,497 services with total Medicare billing of $572,677. Data is available for 2 years (2020–2021), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Oak Ridge, TN
- Active Since 03/10/2006
- Last Updated 10/07/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1780652230
Products in Payments
- COSENTYX (Biological) $1,130
- Humira (Biological) $496.84
- Erivedge (Biological) $406.04
- HUMIRA (Biological) $347.93
- TALTZ (Drug) $309.22
- SKYRIZI (Biological) $298.41
- DUPIXENT DUPILUMAB INJECTION (Biological) $260.78
- DUPIXENT (Biological) $259.70
- Otezla (Drug) $243.26
- EUCRISA (Drug) $217.29
- DORYX (Drug) $167.12
- Cimzia (Drug) $133.34
- DUPIXENT (Drug) $130.26
- IMLYGIC (Biological) $124.76
- ENSTILAR (Drug) $124.60
- Ilumya (Biological) $123.95
- TREMFYA (Drug) $113.46
- Tremfya (Drug) $91.62
- LEVULAN KERASTICK (Drug) $75.68
- Skyrizi (Biological) $64.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Oak Ridge
Dr. Elaine Bunick, Md, MD
Specialist — Payments: $22,808
Specialist $22,808
Joseph Eatherly, M.d, M.D
Specialist — Payments: $2,040
Specialist $2,040
Dr. Charles Mallo, M.d, M.D
Specialist — Payments: $899.84
Specialist $899.84
Mr. Kenneth Miller, M.d, M.D
Specialist — Payments: $199.44
Specialist $199.44
Dr. Pamela Bullock, Md, MD
Specialist — Payments: $94.50
Specialist $94.50
Stephen Harrison, M.d, M.D
Specialist — Payments: $12.43
Specialist $12.43